Contineum Therapeutics
CTNM
#8093
Rank
NZ$0.65 B
Marketcap
NZ$17.30
Share price
1.36%
Change (1 day)
-7.31%
Change (1 year)

Earnings for Contineum Therapeutics (CTNM)

Earnings in 2026 (TTM): -NZ$0.11 Billion

According to Contineum Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$0.11 Billion a decrease over its 2024 earnings that were of -NZ$75.44 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Contineum Therapeutics from 2023 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.11 Billion-6.55%
2025 -NZ$0.11 Billion41.93%
2024 -NZ$75.44 Million-282.38%
2023 NZ$41.36 M